Issued Patents All Time
Showing 1–25 of 75 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404525 | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells | Peter Cabeceiras | 2025-09-02 |
| 12351814 | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells | Peter Cabeceiras | 2025-07-08 |
| 12351815 | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells | Peter Cabeceiras | 2025-07-08 |
| 12319938 | Enhanced virus-like particles and methods of use thereof for delivery to cells | Peter Cabeceiras | 2025-06-03 |
| 12286641 | Methods for increasing efficiency of nuclease-induced homology-directed repair | Benjamin Kleinstiver, Jason Michael Gehrke, Shengdar Tsai, James Angstman, Rebecca Tayler Cottman | 2025-04-29 |
| 12241096 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2025-03-04 |
| 12202861 | Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1 | Y. Esther Tak, Benjamin Kleinstiver | 2025-01-21 |
| 12180520 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2024-12-31 |
| 12173339 | Variants of Cpf1 (Cas12a) with altered PAM specificity | Benjamin Kleinstiver, Alexander Sousa | 2024-12-24 |
| 12152254 | TAL-Tet1 fusion proteins and methods of use thereof | Morgan Maeder, James Angstman | 2024-11-26 |
| 12133884 | Methods of substituting pathogenic amino acids using programmable base editor systems | David Bryson, John W. Evans, Michael S. Packer, Yanfang Fu, Nicole Gaudelli +1 more | 2024-11-05 |
| 12104207 | Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq) | Shengdar Tsai | 2024-10-01 |
| 12065668 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | Morgan Maeder | 2024-08-20 |
| 11976324 | Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents | Vikram Pattanayak, Karl Petri, Kanae Esther Sasaki | 2024-05-07 |
| 11946040 | Adenine DNA base editor variants with reduced off-target RNA editing | Julian Grunewald, Ronghao Zhou | 2024-04-02 |
| 11920152 | Increasing specificity for RNA-guided genome editing | James Angstman, Shengdar Tsai | 2024-03-05 |
| 11898203 | Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents | Vikram Pattanayak, Karl Petri | 2024-02-13 |
| 11859220 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2024-01-02 |
| 11845987 | Highly sensitive in vitro assays to define substrate preferences and sites of nucleic acid cleaving agents | Vikram Pattanayak, Karl Petri | 2023-12-19 |
| 11725228 | Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies | James Angstman, Jason Michael Gehrke | 2023-08-15 |
| 11667677 | Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1 | Y. Esther Tak, Benjamin Kleinstiver | 2023-06-06 |
| 11634731 | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing | Jeffry D. Sander, Morgan Maeder, Yanfang Fu | 2023-04-25 |
| 11624058 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2023-04-11 |
| 11591589 | Variants of Cpf1 (Cas12a) with altered PAM specificity | Benjamin Kleinstiver, Alexander Sousa | 2023-02-28 |
| 11472849 | Methods of transcription activator like effector assembly | Jeffry D. Sander | 2022-10-18 |